“Assessment of Serum Podocalyxin as a Biomarker for Diabetic Nephropathy in Type 2 Diabetes patients in Duhok City”, JLBSR, vol. 3, no. 02, pp. 71–75, Nov. 2022, doi: 10.38094/jlbsr30275.